Home › Kanker (alle vormen) › Michigan › Grand Rapids
Kanker (alle vormen) klinische studies in Grand Rapids, MI
28 studies voor Kanker (alle vormen) zoeken deelnemers op locaties in en rond Grand Rapids (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
RekruterenFase 2
- START Midwest ( Site 1103), Grand Rapids
REC-7735 in Participants With Solid Tumors
RekruterenFase 1/2
- START Midwest, Grand Rapids
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekruterenFase 1
- START Midwest /ID# 279035, Grand Rapids
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
RekruterenFase 1/2
- Corewell Health ( Site 4001), Grand Rapids
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RekruterenFase 1
- Start Midwest, Grand Rapids
A Study of JNJ-87890387 for Advanced Solid Tumors
RekruterenFase 1
- Start Midwest, Grand Rapids
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruterenFase 3
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Cancer Research Consortium of West Michigan, Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- START Midwest, Grand Rapids
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RekruterenFase 1/2
- Corewell Health ( Site 3001), Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruterenFase 1
- START - Midwest Cancer Research Center, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- The Cancer & Hematology Centers, Grand Rapids
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
RekruterenFase 3
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RekruterenFase 1
- START Midwest, Grand Rapids
Project: Every Child for Younger Patients With Cancer
RekruterenObservatieonderzoek
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Site 04, Grand Rapids
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
RekruterenFase 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
RekruterenFase 1
- START Midwest, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
RekruterenFase 1Gezonde vrijwilligers welkom
- BAMF Health Inc., Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- START Midwest, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
RekruterenFase 1/2
- START Midwest, Grand Rapids
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekruterenFase 1
- GSK Investigational Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
RekruterenFase 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruterenFase 1
- START Midwest, Grand Rapids
A Study of YL242 in Subjects With Advanced Solid Tumors
RekruterenFase 1/2
- US-206, Grand Rapids
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
RekruterenObservatieonderzoek
- Corewell Health, Grand Rapids
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekruteren
- Mercy Health Saint Mary's, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
Kanker (alle vormen) studies in andere steden
- Houston, TX121 studies
- New York City, NY109 studies
- Boston, MA85 studies
- Los Angeles, CA74 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Washington, DC58 studies
- Durham, NC58 studies
- Chicago, IL51 studies
- Atlanta, GA49 studies
- Seattle, WA49 studies
- Arlington, VA48 studies
Andere studies in Grand Rapids
- Niet-kleincellige longkanker44 studies
- Colorectale kanker40 studies
- Borstkanker26 studies
- Eierstokkanker24 studies
- Metastatische kanker22 studies
- Prostaatkanker19 studies
- Endometriumkanker18 studies
- Maagkanker18 studies
- Aldermeesklierkanker18 studies
- Melanoom17 studies
- Plaveiselcelcarcinoom van hoofd en hals15 studies
- Drievoudig negatieve borstkanker15 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.